Ismail Ceylan

Ismail Ceylan serves as Président et CEO at Advanced BioDesign. Advanced BioDesign operates in the biotechnology sector with approximately 20.0 employees. The company is headquartered in Lyon, Auvergne-Rhone-Alpes. To date, Advanced BioDesign has raised 9771350.0 in total funding, with the most recent round being Venture (Round not Specified).

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 490 executive contacts are available in Auvergne-Rhone-Alpes.
• • Our database includes 201,469 c suite-level executives.

Outlook WordPress.org YouTube Wordpress.com Mobile Friendly Nginx Quantcast AI

oncology aldh1 cancer treatment tumor resistance biopharmaceutical clinical trial acute myeloid leukemia aml pipeline development small molecule inhibitors predictive tests aldescreen monotherapy safety profile patient stratification chemoresistance drug development therapeutic innovation oncology solutions phase ii trial biotech company patient care cancer metabolism treatment efficacy molecular diagnostics cellular diagnostics preclinical studies cancer stem cells endogenous cell death apoptosis ferroptosis oxidative stress reactive aldehydes aldh inhibitors toxicity prevention immune modulation chemical compounds drug candidates research & development investor relations pharmaceutical partnerships healthcare solutions biotech investments health equity therapeutic targets treatment protocols patient outcomes genotoxic effects hospital & health care

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Ismail Ceylan, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Ismail Ceylan's Position in the MessageCEO Database

• •Ismail Ceylan is 1 of 1 verified executive contact we track at Advanced BioDesign.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •487 verified executive contacts in Auvergne-Rhone-Alpes are in the database.
• •3 verified contacts work at biotechnology companies in the 20.0 employee range (same size as Advanced BioDesign).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Ismail Ceylan directly?

Ismail Ceylan's verified email address is available to MessageCEO Pro subscribers. They currently serve as Président et CEO at Advanced BioDesign. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Ismail Ceylan work for?

Ismail Ceylan is Président et CEO at Advanced BioDesign, a company in the biotechnology sector with 20.0 employees. The company is based in Lyon, Auvergne-Rhone-Alpes.

Can I pitch or sell to Ismail Ceylan?

As Président et CEO at Advanced BioDesign, Ismail Ceylan is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Ismail Ceylan directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Ismail Ceylan in?

Ismail Ceylan works in the biotechnology industry as Président et CEO at Advanced BioDesign. MessageCEO provides verified contact information for executives across all major industries.

Is Ismail Ceylan's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Ismail Ceylan's profile is kept up-to-date with the latest available information.

Last updated: May 25, 2026